BDBrian R. Davidson

Brian R. Davidson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brian R. Davidson has a total of 80 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Soluble CD163, a Marker of Macrophage Activation, is Increased in Early Allograft Dysfunction after Liver Transplantation

    by K.L. Thomsen, R. Jalan, F.P. Robertson, P. Holland-Fischer, B.R. Davidson, R. Mookerjee, H.J. Møller, H. Grønbæk

  • Radioisotope bone scans in the preoperative staging of hepatopancreatobiliary cancer

    by H. Sheth, S. S. Javed, A. J. W. Hilson, J. R. Buscombe, B. R. Davidson

    Background: The aim of the study was to determine the value of radioisotope bone scans in the preoperative staging of patients with hepatopancreatobiliary (HPB) cancer. Methods: Bone scanning was performed as part of a routine staging protocol in 402 consecutive patients with HPB cancer over a period of 5 years. Patients with positive bone scans underwent coned radiography, computed tomography with review on bone windows, or a bone biopsy. Bone scans were reviewed along with staging investigations, surgical and histological findings. Patients were followed for a minimum of 6 months. Results: There were 171 patients with colorectal liver metastases, 106 with suspected pancreatic cancer, 47 with hepatocellular cancer, 52 with gallbladder cancer or cholangiocarcinoma, and 26 with other types of HPB cancer. Bone scans were negative in 377 patients (93·8 per cent) and positive in 25 patients (6·2 per cent). Of the 25 positive scans, 16 were falsely positive as a result of degenerative bone disease. Of nine patients with a true-positive bone scan, four had locally irresectable disease and four distant metastases. In only one patient did the bone scan result alone influence the decision to resect the HPB cancer. Overall sensitivity was 100 per cent, specificity 95·9 per cent, positive predictive value 36·0 per cent and negative predictive value 100 per cent. Conclusion: Bone scanning should not be included in the routine staging protocol for HPB cancer.


  • Open Access

    Prospective study of contrast-enhanced computed tomography, computed tomography during arterioportography, and magnetic resonance imaging for staging colorectal liver metastases for liver resection

    by S. Bhattacharjya, T. Bhattacharjya, S. Baber, J. M. Tibballs, A. F. Watkinson, B. R. Davidson

    Background This study compared the value of contrast-enhanced helical computed tomography (CT), CT during arterioportography (CTAP), and contrast-enhanced magnetic resonance imaging (MRI) for staging patients with colorectal liver metastases. Methods One hundred and twenty patients with known or suspected colorectal liver metastases were evaluated prospectively. MRI and CTAP were performed within 3 weeks of CT in patients with potentially resectable tumours. Results of imaging were compared with findings at surgery, intraoperative ultrasonography and histological examination. Results Twenty patients were not considered for liver resection following CT. The remaining 100 patients underwent CT and CTAP, 85 of whom had CT, CTAP and MRI. The sensitivity and specificity were 73·0 and 96·5 per cent for CT, 87·1 and 89·3 per cent for CTAP, and 81·9 and 93·2 per cent for MRI. Positive predictive values were 89·7, 87·5 and 87·5 per cent respectively. Receiver–operator characteristic analysis gave an accuracy on a segment-by-segment analysis of 0·73 for CT, 0·87 for CTAP and 0·82 for MRI. Combining information from CT and CTAP, CT and MRI, or all three modalities, did not significantly increase the percentage of patients staged correctly (71, 72 and 76 per cent respectively). Conclusion The diagnostic accuracy of spiral CT, MRI and CTAP was similar. Combining modalities did not improve accuracy.


  • Continuous infusion ofN-acetylcysteine reduces liver warm ischaemia–reperfusion injury

    by G. K. Glantzounis, W. Yang, R. S. Koti, D. P. Mikhailidis, A. M. Seifalian, B. R. Davidson

    Background: N‐acetylcysteine (NAC) may modulate the initial phase (less than 2 h) of liver warm ischaemia–reperfusion (IR) injury but its effect on the late phase remains unclear. The present study investigated the role of NAC during the early and late phases in a rabbit lobar IR model. Methods: Liver ischaemia was induced by inflow occlusion to the median and left liver lobes for 60 min, followed by 7 h of reperfusion. In the NAC group (n = 6), NAC was administered intravenously at 150 mg per kg over the 15 min before reperfusion and maintained at 10 mg per kg per h during reperfusion. In the IR group (n = 6), 20 ml 5 per cent dextrose was infused over the 15 min before reperfusion and continued at a rate of 10 ml/h. Animals in a sham operation group (n = 6) underwent laparotomy but no liver ischaemia. All animals were killed at the end of the experiment. Results: Intracellular tissue oxygenation was improved after the second hour of reperfusion in animals treated with NAC compared with that in the IR group (P = 0·023). Hepatic microcirculation improved after 5 h of reperfusion (P = 0·036) and liver injury was reduced after 5 h, as indicated by alanine aminotransferase activity (P = 0·007) and indocyanine green clearance (uptake, P = 0·001; excretion, P = 0·032). Conclusion: The main protective effect of NAC becomes apparent 5 h after hepatic ischaemic injury. Copyright © 2004 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.


  • Open Access

    Induction of adhesion molecule expression in liver ischaemia–reperfusion injury is associated with impaired hepatic parenchymal microcirculation

    by M El-Wahsh, A M Seifalian, B J Fuller, K Rolles, B R Davidson

    Background Activated neutrophils may be important mediators in liver ischaemia–reperfusion injury (I/R). Adhesion of leucocytes to the endothelial cell surface is a result of activation of cell adhesion molecules. The aim of this study was to investigate the effect of I/R on the hepatic microcirculation (HM) and intercellular adhesion molecule (ICAM) 1 expression. Methods Four groups of six Sprague–Dawley rats underwent laparotomy for liver exposure. Group 1 acted as controls, and groups 2–4 underwent partial liver ischaemia for 30, 45 and 60 min respectively followed by reperfusion for 60 min. Flow in the HM was measured by laser Doppler flowmetry. Liver biopsies were taken at the end of the reperfusion period. ICAM-1 expression was assessed by immunohistochemistry (graded 0–3). Results Mean flow in the HM was significantly reduced with I/R (mean(s.e.m.) red cell flux 140(21), 52(3) and 43(2) with 30, 45 and 60 min ischaemia compared with control 230(17); all P < 0·001). ICAM-1 expression was significantly induced (mean(s.e.m.) 1·30(0·21), 2·50(0·22) and 2·80(0·17) with 30, 45 and 60 min ischaemia versus control 0·50(0·22); all P < 0·001). Conclusion I/R produced a significant upregulation of ICAM-1 expression which correlated with impaired flow in the HM.


  • Protection of the Liver by Ischemic Preconditioning: A Review of Mechanisms and Clinical Applications

    by Rahul S. Koti, Alexander M. Seifalian, Brian R. Davidson

    Ischemic preconditioning refers to the endogenous mechanism of protection against a sustained ischemic insult following an initial, brief ischemic stimulus. Ischemia-reperfusion injury of the liver is a major cause of morbidity and mortality in liver surgery and transplantation and ischemic preconditioning is a promising strategy for improving the outcome of liver surgery. The preconditioning phenomenon was first described in a canine model of myocardial ischemia-reperfusion injury in 1986 and since then has been shown to exist in other organs including skeletal muscle, brain, kidneys, retina and liver. In the liver, the preconditioning effect has been demonstrated in rodents and a recent study has demonstrated human clinical benefits of preconditioning during hemihepatectomies. Ischemic preconditioning has been described as an adaptive response and although the precise mechanism of hepatoprotection from preconditioning is unknown it is likely to be a receptor-mediated process. Several hypotheses have been proposed and this review assesses possible mechanisms of ischemic preconditioning and its role in hepatic surgery and liver transplantation. The future lies in defining the mechanisms of the ischemic preconditioning effect to allow drug targeting to induce the preconditioning response.


  • Strategies to Increase the Resectability of Liver Metastases from Colorectal Cancer

    by G. Fusai, B.R. Davidson

    Liver resection can provide long-term survival and cure for patients with colorectal liver metastases but is feasible in only 15–25% of patients. In the last few years several major developments have contributed to increase this resectability rate. Neo-adjuvant chemotherapy can provide response rates as high as 50%, allowing surgery in about 10–15% of patients initially deemed unresectable. Patients requiring extensive liver resections with an anticipated small residual liver volume can undergo portal vein embolization to reduce the risk of postoperative liver failure by inducing hypertrophy of the remnant liver. Extensive bilobar disease can be treated by two-stage hepatectomy, with an interval to allow liver regeneration. Ablation techniques can be combined with hepatic resection to reduce local recurrence from incomplete surgical resection margins or to destroy contralateral tumor deposits. Finally, for patients with tumors involving the inferior vena cava or the hepatic veins, in which conventional resection is not feasible, in situ hypothermia or bench resection with reimplantation are suitable for very selected patients. Downstaging strategies may increase the resectability rate of colorectal liver metastases by over 20%.


  • Telemedicine in surgery

    by L. H. Eadie, A. M. Seifalian, B. R. Davidson

    Background: Telemedicine is influencing surgical training, allows mentoring, proctoring and teleconferencing, and is increasingly being applied to carry out remote surgical procedures. A systematic review of the telemedicine systems available, along with a critical appraisal of their application, potential and limitations in the surgical field, has been undertaken. Method: Medline, Ovid and internet searches were carried out using the keywords ‘telesurgery’, ‘telepresence surgery’ and ‘telemedicine and surgery’, along with hand searches of the two peer-reviewed telesurgery journals. Results: Telementoring and teleconferencing have been used widely for surgical teaching and training. Two clinical telesurgery systems are currently available and have been trialled in patients undergoing a variety of operations including cholecystectomy, coronary artery bypass, prostatectomy and gastroplasty. Most studies have reported successful outcomes but with prolonged operating times. In 2002 the first long-distance telesurgery procedure was successfully performed. Conclusion: Telemedicine has huge potential to alter surgical practice but improvements are required in telesurgical technology with respect to tactile feedback, instrumentation, telecommunication speed and availability. Issues of liability, legislation, cost and benefit require clarification. The future of telemedicine in surgery may lie in facilitating complex minimally invasive techniques.


  • Open Access

    Pk11195, a mitochondrial benzodiazepine receptor antagonist, reduces apoptosis threshold in Bcl-XL and Mcl-1 expressing human cholangiocarcinoma cells

    by A C Okaro, D A Fennell, M Corbo, B R Davidson, F E Cotter

    Background: Cholangiocarcinoma cells express high levels of the antiapoptotic proteins Bcl-XL and Mcl-1 and are markedly chemo- and radioresistant. Mitochondria have emerged as central players in apoptosis. Antiapoptotic members of the Bcl-2 protein family localise to the outer mitochondrial membrane and regulate mitochondrial release of apoptogenic proteins. Mitochondrial benzodiazepine receptor (mBzR) ligands have been shown to reverse Bcl-2 action and facilitate apoptosis. Aim: We evaluated the ability of the mBzR antagonist Pk11195 to overcome preapoptotic mitochondrial dysfunction in Egi-1 and Tfk-1, two human cholangiocarcinoma cell lines expressing high levels of Bcl-XL and Mcl-1. Materials and methods: Cells growing in culture were used to perform in vitro experiments over 48–96 hours following treatment. The cytotoxic agents used were 5 fluorouracil 10 μM and etoposide (Vp16) 10 μM, together with ultraviolet and 0.5–1 Gy x ray irradiation with or without 75 μM Pk11195. Apoptosis and mitochondrial dysfunction were measured at single cell resolution by flow cytometry using the mitochondrial fluorochrome DiOC6(3). Severe combined immunodeficient non-obese diabetic (SCID-NOD) mice with subcutaneous xenografts using the Egi-1 and Tfk-1 cell lines were treated with etoposide with or without addition of Pk11195 over a 72 hour period during which time the xenograft growth patterns were monitored. Results: In vitro, the effect of Pk11195 on induction of apoptosis in cholangiocarcinoma cells following stimulation by chemotherapy or radiotherapy was found to be both time and dose dependent, with Pk11195 increasing rates of apoptosis by 50–95%. Intraperitoneal administration of Pk11195 in combination with Vp16 was found to increase the growth inhibiting effects of Vp16 on xenografts during the treatment phase. PK11195 75 μM on its own had no intrinsic cytotoxic efficacy. Conclusion: This is the first study to demonstrate that functional antagonism of coexpressed Bcl-XL and Mcl-1 proteins using the mBzR antagonist Pk11195 can facilitate apoptosis in cholangiocarcinoma following chemotherapy and radiotherapy.


  • Open Access

    The relationship of hepatic tissue oxygenation with nitric oxide metabolism in ischemic preconditioning of the liver

    by Rahul S. Koti, Alexander M. Seifalian, Alan G. McBride, Wenxuan Yang, Brian R. Davidson

    Ischemic preconditioning (IPC) may increase the hepatic tolerance of ischemic injury during liver surgery and transplantation via nitric oxide (NO) formation. This study investigates the effect of IPC on hepatic tissue oxygenation and the role of NO stimulation and inhibition on the preconditioning effect in the rat liver. Study groups had 1) sham laparotomy; 2) 45‐min lobar liver ischemia and 2‐h reperfusion (IR); 3) IPC with 5‐min ischemia and 10‐min reperfusion before IR; 4) L‐arginine before IR; and 5) Nω‐Nitro‐L‐arginine methyl ester (L‐NAME) + IPC before IR. Hepatic tissue oxygenation was monitored by near‐infrared spectroscopy. Plasma alanine aminotransferase and plasma nitrite/nitrate were measured. Following IR there was significant decrease in oxyhemoglobin and cytochrome oxidase and an increase in deoxyhemoglobin ( P A redox state, P0.05 vs IR). In contrast, inhibition of NO synthesis blocked the effect of IPC and further impaired tissue oxygenation (decreased cytochrome oxidase Cu A redox state and increased deoxyhemoglobin, both P P< 0.05 vs IR). Hepatic tissue oxygenation correlated significantly with ALT and plasma nitrite/nitrate. Ischemic preconditioning significantly improved hepatic intra cellular oxygenation and reduced hepatocellular injury. NO stimulation reduced hepatocellular injury, whereas inhibition of nitric oxide synthesis blocked the effect of IPC and reduced tissue oxygenation and increased hepatocellular injury.